Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Azonal steatosis correlates with disease severity and poor outcome of nonalcoholic fatty liver disease.

Journal of digestive diseases - 1 Jan 2023

Tong Xiao Fei, Zhao Xin Yan, Sun Ya Meng, Shi Yi Wen, Li Min, Wu Xiao Ning, Zhao Jing Jie, Yang Li Ling, Lu Zheng Zhao, Ou Xiao Juan, Jia Ji Dong, Wang Qian Yi, You Hong

Abstract excerpt

OBJECTIVES: In this study we aimed to assess the clinicopathological characteristics and long-term prognosis of patients with nonalcoholic fatty liver disease (NAFLD) having distinct steatosis distribution patterns. METHODS: Clinicopathological data of 238 individuals with biopsy-confirmed NAFLD were collected. Nonalcoholic steatohepatitis-clinical research network (NASH-CRN) and steatosis, activity and fibrosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibrosis
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Non-alcoholic Fatty Liver Disease

Share to Patient Acuity

Source

Identifiers

PMID: 36908183
DOI: 10.1111/1751-2980.13163

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Azonal steatosis correlates with disease severity and poor outcome of nonalcoholic fatty liver disease.PMID 36908183Read ↗

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and BeyondSemantic proximity Read ↗

Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Natural History of NAFLDSemantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Clinical and pathological characteristics of metabolic dysfunction-associated steatotic liver disease and the key role of epigenetic regulation: implications for molecular mechanism and treatmentSemantic proximity Read ↗

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk FactorsSemantic proximity Read ↗

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.Semantic proximity Read ↗

Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease.Semantic proximity Read ↗

Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.Semantic proximity Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.